Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

INTRODUCTION: Most breast cancers that occur in women with germline BRCA1 mutations are estrogen receptor-negative (ER-) and also typically lack expression of progesterone receptor (PR) and HER2 overexpression. We undertook a study to assess the clinical factors that predict for an estrogen receptor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tung, Nadine, Wang, Yihong, Collins, Laura C, Kaplan, Jennifer, Li, Hailun, Gelman, Rebecca, Comander, Amy H, Gallagher, Bridget, Fetten, Katharina, Krag, Karen, Stoeckert, Kathryn A, Legare, Robert D, Sgroi, Dennis, Ryan, Paula D, Garber, Judy E, Schnitt, Stuart J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880433/
https://ncbi.nlm.nih.gov/pubmed/20149218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2478
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki